Komori
Governance8283PALTAC CORPORATIONTrading & Wholesale

Matters Concerning Controlling Shareholders

Reported that the parent company, MEDIPAL HOLDINGS CORPORATION, holds 52.44% of the voting rights, as well as the relationship with the parent company and measures to protect minority shareholders. The company has also resolved to support MEDIPAL HOLDINGS CORPORATION's tender offer and recommend that shareholders tender their shares, with plans to make the company a wholly owned subsidiary and delist it.

Worth reading
81Important
Scored from 2 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
52.44
Voting rights ownership ratio (%)
Wording
Definitive
How definitive the wording is.

Governance structure

Controlling shareholder
MEDIPAL HOLDINGS CORPORATION, with a 52.44% direct voting rights ownership ratio52.44%Voting rights

When one company holds most of the voting rights, its wishes are more likely to prevail in management. How the interests of minority shareholders are protected is a key issue.

Number of directors13 directors in total, including 7 independent outside directors (the total number of outside directors is not disclosed)
Number of independent officers7Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Committee2
Special Committee (comprising all independent outside directors and independent outside audit and supervisory board members); the percentage of outside committee members can be determined from the disclosure to be 100%but the number is not disclosed
Changes this time

Changes from the previous report are not disclosed. The report states that on 11 May 2026, the company resolved to support the tender offer and recommend that shareholders tender their shares, and that it plans to become a wholly owned subsidiary and delist.

Governance structure
ItemDetails
Number of directors13 directors in total, including 7 independent outside directors (the total number of outside directors is not disclosed)
Number of independent officersIn addition to 7 independent outside directors, the number of independent outside audit and supervisory board members is not disclosed
CommitteeSpecial Committee (comprising all independent outside directors and independent outside audit and supervisory board members); the percentage of outside committee members can be determined from the disclosure to be 100%, but the number is not disclosed
Controlling shareholderMEDIPAL HOLDINGS CORPORATION, with a 52.44% direct voting rights ownership ratio
Changes this timeChanges from the previous report are not disclosed. The report states that on 11 May 2026, the company resolved to support the tender offer and recommend that shareholders tender their shares, and that it plans to become a wholly owned subsidiary and delist.
Items this document does not state (3)
Corporate Governance StructurePolicy on cross-shareholdingsTakeover defenses

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To inform investors about the company's position within the parent company's group, measures to ensure independence, monitoring of the risk of conflicts of interest with the controlling shareholder, and the protection of minority shareholders. Regarding the tender offer, the parent company intends to make the company a wholly owned subsidiary.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Matters Concerning Controlling Shareholders | PALTAC CORPORATION (8283) timely disclosure | Komori